Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Herzfeld Caribbean Basin Fund | CUBA | Dec 27, 2024 | 2.52 | -0.98 |
The Honest Company | HNST | Dec 27, 2024 | 6.93 | -1.70 |
The Intergroup | INTG | Dec 27, 2024 | 14.27 | 0.00 |
The J.M Smucker Company | SJM | Dec 27, 2024 | 110.62 | -0.27 |
The Joint | JYNT | Dec 27, 2024 | 9.90 | -2.75 |
The Marygold Companies | MGLD | Dec 27, 2024 | 1.81 | +4.02 |
The ODP | ODP | Dec 27, 2024 | 22.92 | -1.46 |
The OLB Group | OLB | Dec 27, 2024 | 1.88 | +14.63 |
The Oncology Institute | TOI | Dec 27, 2024 | 0.32 | +19.03 |
The ONE Group Hospitality | STKS | Dec 27, 2024 | 2.91 | -0.68 |
The Pennant Group | PNTG | Dec 27, 2024 | 26.63 | -1.66 |
The Real Brokerage | REAX | Dec 27, 2024 | 4.73 | -1.87 |
The Real Estate Select Sector SPDR Fund | XLRE | Dec 27, 2024 | 40.54 | -0.81 |
The RealReal | REAL | Dec 27, 2024 | 10.86 | -1.18 |
The RMR Group A | RMR | Dec 27, 2024 | 20.49 | -1.59 |
The Shyft Group | SHYF | Dec 27, 2024 | 11.33 | -4.95 |
The Trade Desk A | TTD | Dec 27, 2024 | 121.39 | -1.68 |
The9 ADR | NCTY | Dec 27, 2024 | 15.71 | -2.24 |
TherapeuticsMD | TXMD | Dec 27, 2024 | 1.09 | 0.00 |
Theratechnologies | THTX | Dec 27, 2024 | 1.79 | -2.19 |
Theravance Biopharma | TBPH | Dec 27, 2024 | 9.59 | -2.74 |
Theriva Biologics | TOVX | Dec 27, 2024 | 1.47 | -6.96 |
Thermo Fisher Scientific | TMO | Dec 27, 2024 | 526.07 | -0.21 |
Thermon Group | THR | Dec 27, 2024 | 28.62 | -1.45 |
Third Coast Bancshares | TCBX | Dec 27, 2024 | 34.13 | -2.21 |
Third Harmonic | THRD | Dec 27, 2024 | 10.26 | -5.26 |
Thomson Reuters | TRI | Dec 27, 2024 | 162.00 | -0.47 |
Thor Industries | THO | Dec 27, 2024 | 95.37 | -1.53 |
Thornburg Income Builder Opportunities Fund | TBLD | Dec 27, 2024 | 16.50 | -0.48 |
ThredUp A | TDUP | Dec 27, 2024 | 1.39 | -5.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.